Provectus Biopharmaceuticals Inc (PVCT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Provectus Biopharmaceuticals Inc (PVCT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7494
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], pediatric solid tumors and other tumors. It is developing a new class of drugs based on halogenated xanthenes such as Rose Bengal. Provectus offers PH-10 for psoriasis and atopic dermatitis. The company conducts research on ongoing clinical trials for indications including breast cancers, melanoma, head and neck cancers, basal cell carcinoma and squamous cell carcinoma. It operates through its offices in Tennessee and New York, the US. Provectus is headquartered in Knoxville, Tennessee, the US.

Provectus Biopharmaceuticals Inc (PVCT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Provectus Biopharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Provectus Biopharma Raises USD0.8 Million in Private Placement of Shares 10
Provectus Biopharma Raises USD1 Million in Private Placement of Shares 11
Provectus Biopharma Raises USD5 Million in Private Placement of Shares 12
Provectus Biopharma Raises USD3.6 Million in Private Placement of Shares 13
Provectus Biopharma Raises USD4.2 Million in Private Placement of Shares 14
Provectus Pharma Announces Private Placement Of Shares For Up To US$30 Million 15
Provectus Pharma Completes Private Placement Of Units For US$2.1 Million 16
Provectus Biopharmaceuticals Inc – Key Competitors 17
Provectus Biopharmaceuticals Inc – Key Employees 18
Provectus Biopharmaceuticals Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Apr 20, 2017: Provectus Biopharmaceuticals Reestablishes Strategic Advisory Board 20
Feb 23, 2017: Provectus Biopharmaceuticals Appoints Bruce Horowitz And Dominic Rodrigues As Special Advisers To The Board Of Directors 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Provectus Biopharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Provectus Biopharma Raises USD0.8 Million in Private Placement of Shares 10
Provectus Biopharma Raises USD1 Million in Private Placement of Shares 11
Provectus Biopharma Raises USD5 Million in Private Placement of Shares 12
Provectus Biopharma Raises USD3.6 Million in Private Placement of Shares 13
Provectus Biopharma Raises USD4.2 Million in Private Placement of Shares 14
Provectus Pharma Announces Private Placement Of Shares For Up To US$30 Million 15
Provectus Pharma Completes Private Placement Of Units For US$2.1 Million 16
Provectus Biopharmaceuticals Inc, Key Competitors 17
Provectus Biopharmaceuticals Inc, Key Employees 18
Provectus Biopharmaceuticals Inc, Subsidiaries 19

List of Figures
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Provectus Biopharmaceuticals Inc (PVCT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • American Airlines Group Inc (AAL):企業の財務・戦略的SWOT分析
    American Airlines Group Inc (AAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Petroliam Nasional Berhad:企業の戦略・SWOT・財務情報
    Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Finbar Group Ltd (FRI):企業の財務・戦略的SWOT分析
    Finbar Group Ltd (FRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CSI Compressco LP (CCLP):石油・ガス:M&Aディール及び事業提携情報
    Summary CSI Compressco LP (CSI), formerly Compressco Partners LP, a subsidiary of TETRA Technologies Inc, is an oilfield consulting company that offers compression services and equipment for natural gas and oil production, transportation, and storage. The company's products include real-time compres …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gabather AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Gabather AB (Gabather) is a developer of new drug candidates for the treatment of central nervous system diseases. The company spans its expertise in the development of anti-psychotics, anti-depressants and anxiolytics, analgesics, and cognition-enhancing treatments. It offers drug candidate …
  • Hebei Construction Group Co Ltd (1727):企業の財務・戦略的SWOT分析
    Hebei Construction Group Co Ltd (1727) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Brazil Fast Food Corp.:企業の戦略・SWOT・財務分析
    Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report Summary Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Invenergy LLC:企業の発電所・SWOT分析2018
    Invenergy LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Fuerst Day Lawson Ltd:企業の戦略・SWOT・財務情報
    Fuerst Day Lawson Ltd - Strategy, SWOT and Corporate Finance Report Summary Fuerst Day Lawson Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Merit Medical Systems Inc (MMSI):企業の製品パイプライン分析
    Summary Merit Medical Systems Inc (Merit Medical) offers a range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolytic cathe …
  • Vilniaus Degtine AB:企業の戦略・SWOT・財務情報
    Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report Summary Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Texas Instruments Inc.:企業の戦略・SWOT・財務分析
    Texas Instruments Inc. - Strategy, SWOT and Corporate Finance Report Summary Texas Instruments Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Vina Concha y Toro SA:企業の戦略・SWOT・財務情報
    Vina Concha y Toro SA - Strategy, SWOT and Corporate Finance Report Summary Vina Concha y Toro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ASGN Inc (ASGN):企業の財務・戦略的SWOT分析
    Summary ASGN Inc (ASGN), formerly known as On Assignment Inc, provides professionals for technology, life sciences, and creative sectors. It offers qualified professionals and human capital services. The company’s cybercoders recruits professionals for engineering, technology, sales, executive, fina …
  • Hoteli Maestral d.d.:企業の戦略・SWOT・財務情報
    Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report Summary Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Pronto Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary Pronto Diagnostics Ltd (PDL) is a medical device company that offers molecular diagnostic products and services. The company develops, produces and distributes SNP-detection kits providing assays for detecting polymorphisms in DNA sequences with genetic diseases and predisposition to disease …
  • National HealthCare Corp (NHC):製薬・医療:M&Aディール及び事業提携情報
    Summary National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing, Alzheimer's and memory care, residential and assisted living, home care, hospice care and long term care insurance serv …
  • Precision Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical stage biotechnology company. The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor specific antigens, companion diagnostic programs, and diagnostic …
  • Marston’s PLC:企業の戦略・SWOT・財務情報
    Marston's PLC - Strategy, SWOT and Corporate Finance Report Summary Marston's PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆